GGrantIndex
← Leaderboards

John David Beckham

University Of Colorado Denver

$3,995,571
Attributed
$3,995,571
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $833.6K · FY200825
$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,995,571 · 3
VA$0 · 1

By mechanism

R01$3,194,438 · 2
K08$801,133 · 1
I01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Virus Diseases

Research focus

Virus DiseasesVirusBrainViralNeuronsWest Nile VirusInfectionGenesKnockout MicePathway InteractionsMediatingBrain TissuePathogenesisInsightMouse ModelMutantMutationT Cell ResponseEnvironmentSiteEventSignal TransductionGrowthNerve Degeneration

Grant awards (22)

Development of a vaccination platform for emerging flavivirus infections$459,768
R01 · FY2025 · AI · contact PI
Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain$300,395
R01 · FY2025 · NS · contact PI
Development of a vaccination platform for emerging flavivirus infections$459,768
R01 · FY2024 · AI · contact PI
Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain$307,383
R01 · FY2024 · NS · contact PI
Development of a vaccination platform for emerging flavivirus infections$436,523
R01 · FY2023 · AI · contact PI
Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain$397,039
R01 · FY2023 · NS · contact PI
Targeting Innate Immunity as A Therapeutic Intervention for Parkinsons Disease$0
I01 · FY2023 · VA · contact PI
Development of a vaccination platform for emerging flavivirus infections$436,523
R01 · FY2022 · AI · contact PI
Determining the mechanism of alpha-synuclein dependent innate immune responses in the brain$397,039
R01 · FY2022 · NS · contact PI
Targeting Innate Immunity as A Therapeutic Intervention for Parkinsons Disease$0
I01 · FY2022 · VA · contact PI
Targeting Innate Immunity as A Therapeutic Intervention for Parkinsons Disease$0
I01 · FY2021 · VA · contact PI
Defining the Mechanism of Alpha-synuclein Dependent Restriction of Viral Neuroinvasion$0
I01 · FY2020 · VA · contact PI
Defining the Mechanism of Alpha-synuclein Dependent Restriction of Viral Neuroinvasion$0
I01 · FY2019 · VA · contact PI
Defining the Mechanism of Alpha-synuclein Dependent Restriction of Viral Neuroinvasion$0
I01 · FY2018 · VA · contact PI
Defining the Mechanism of Alpha-synuclein Dependent Restriction of Viral Neuroinvasion$0
I01 · FY2017 · VA · contact PI
Mechanisms of Apoptosis in Virus-Infected Neurons$141,457
K08 · FY2012 · AI · contact PI
Mechanisms of Apoptosis in Virus-Infected Neurons$141,457
K08 · FY2011 · AI · contact PI
Mechanisms of Apoptosis in Virus-Infected Neurons$140,483
K08 · FY2010 · AI · contact PI
Mechanisms of Apoptosis in Virus-Infected Neurons$49,582
K08 · FY2010 · AI · contact PI
Mechanisms of Apoptosis in Virus-Infected Neurons$139,537
K08 · FY2009 · AI · contact PI
Mechanisms of Apoptosis in Virus-Infected Neurons$49,999
K08 · FY2009 · AI · contact PI
Mechanisms of Apoptosis in Virus-Infected Neurons$138,618
K08 · FY2008 · AI · contact PI